1. Home
  2. OVID vs FEDU Comparison

OVID vs FEDU Comparison

Compare OVID & FEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • FEDU
  • Stock Information
  • Founded
  • OVID 2014
  • FEDU 2007
  • Country
  • OVID United States
  • FEDU China
  • Employees
  • OVID N/A
  • FEDU N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • FEDU
  • Sector
  • OVID Health Care
  • FEDU
  • Exchange
  • OVID Nasdaq
  • FEDU NYSE
  • Market Cap
  • OVID 24.0M
  • FEDU 20.0M
  • IPO Year
  • OVID 2017
  • FEDU 2017
  • Fundamental
  • Price
  • OVID $0.29
  • FEDU $7.70
  • Analyst Decision
  • OVID Strong Buy
  • FEDU
  • Analyst Count
  • OVID 6
  • FEDU 0
  • Target Price
  • OVID $3.03
  • FEDU N/A
  • AVG Volume (30 Days)
  • OVID 376.8K
  • FEDU 7.4K
  • Earning Date
  • OVID 05-20-2025
  • FEDU 12-20-2024
  • Dividend Yield
  • OVID N/A
  • FEDU 29.61%
  • EPS Growth
  • OVID N/A
  • FEDU N/A
  • EPS
  • OVID N/A
  • FEDU 0.12
  • Revenue
  • OVID $566,000.00
  • FEDU $27,971,139.00
  • Revenue This Year
  • OVID N/A
  • FEDU N/A
  • Revenue Next Year
  • OVID $36.11
  • FEDU N/A
  • P/E Ratio
  • OVID N/A
  • FEDU $64.61
  • Revenue Growth
  • OVID 44.39
  • FEDU 141.14
  • 52 Week Low
  • OVID $0.24
  • FEDU $3.69
  • 52 Week High
  • OVID $3.43
  • FEDU $22.70
  • Technical
  • Relative Strength Index (RSI)
  • OVID 39.90
  • FEDU 48.16
  • Support Level
  • OVID $0.28
  • FEDU $7.30
  • Resistance Level
  • OVID $0.33
  • FEDU $7.71
  • Average True Range (ATR)
  • OVID 0.03
  • FEDU 0.36
  • MACD
  • OVID 0.00
  • FEDU 0.12
  • Stochastic Oscillator
  • OVID 16.97
  • FEDU 83.55

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)

Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.

Share on Social Networks: